Study: Generic biologics not much cheaper

May 03, 2007

A U.S. study has determined generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name drugs.

Biologics are drugs, vaccines and other medicines produced by living cells in controlled circumstances, but there is no established process for the review and approval of generic versions of biologic products, such as insulin.

"Congress and the (U.S. Food and Drug Administration) are currently addressing this issue and developing a process for the oversight of generic biologics, partially in hopes of generating significant cost savings for consumers and insurers," said Duke University Professor Kevin Schulman. "However, our research indicates that any savings to be expected from the addition of generic biologics to the marketplace will be significantly less than the savings generally available from generic pharmaceuticals."

The study, which also included Professors David Ridley and Henry Grabowski as authors, is to be published in the journal Managerial and Decision Economics.

Copyright 2007 by United Press International

Explore further: Seniors successfully withdraw from meds

add to favorites email to friend print save as pdf

Related Stories

Congress: Safety agency mishandled GM recall

30 minutes ago

Both houses of Congress scolded the U.S. highway safety agency Tuesday over its tardy handling of a deadly problem with General Motors cars, questioning whether it is competent to guarantee the safety of ...

Alibaba post-IPO structure gives insiders control

40 minutes ago

Control over Alibaba Group will stay in the hands of founder Jack Ma and other company veterans after the Chinese e-commerce giant goes public on the New York Stock Exchange in a record busting share sale.

Recommended for you

Seniors successfully withdraw from meds

5 hours ago

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

23 hours ago

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments : 0